Cano Health (CANO) Misses Q2 EPS by 1c, Offers Guidance

August 9, 2022 4:52 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Cano Health (NYSE: CANO) reported Q2 EPS of ($0.03), $0.01 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $689.4 million versus the consensus estimate of $712.61 million.


Cano Health sees FY2022 revenue of $2.85-2.9 billion, versus the consensus of $2.86 billion.

For earnings history and earnings-related data on Cano Health (CANO) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities